Preparation of 4,4′-bis(2-bromoacetyl)biphenyl_Kain Industrial Additive
Background and overview[1] 4,4’-Bis(2-bromoacetyl)biphenyl is a key intermediate in the synthesis of the anti-hepatitis C drug daclatasvir. Daclatasvir is a new hepatitis C drug developed by Bristol-M…
Preparation of 4,4′-bis(2-bromoacetyl)biphenyl_Kain Industrial Additive
Background and overview[1] 4,4’-Bis(2-bromoacetyl)biphenyl is a key intermediate in the synthesis of the anti-hepatitis C drug daclatasvir. Daclatasvir is a new hepatitis C drug developed by Bristol-M…
